LCAT and hyperlipidemia: Additionally, 6-gingerol prevents HFD-induced hyperlipidemia by modulating the expression of enzymes critical to cholesterol metabolism, including lecithin-cholesterol acyltransferase (LCAT) and LPL, as well as inflammatory markers such as TNF-α and IL-6 [44].